| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order | 474 | Newsfile | Calgary, Alberta--(Newsfile Corp. - July 7, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company"), provides an update regarding the filing of its audited annual financial... ► Artikel lesen | |
| 06.07. | Simply Solventless Concentrates Ltd: Simply Solventless to file 2025 results July 17 | 1 | Stockwatch | ||
| 06.07. | Simply Solventless Concentrates Ltd: Simply Solventless has no material changes | 2 | Stockwatch | ||
| 04.07. | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order | 1.075 | Newsfile | Calgary, Alberta--(Newsfile Corp. - July 4, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company") provides an update regarding the filing of its audited annual financial... ► Artikel lesen | |
| 19.06. | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order | 632 | Newsfile | Calgary, Alberta--(Newsfile Corp. - June 18, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company"), provides an update regarding the filing of its audited annual financial... ► Artikel lesen | |
| 12.06. | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order | 549 | Newsfile | Calgary, Alberta--(Newsfile Corp. - June 11, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company"), provides an update regarding the filing of its audited annual financial... ► Artikel lesen | |
| 29.05. | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements, Q1 Financial Statements, Related Management's Discussion and Analysis and Management Cease Trade Order | 528 | Newsfile | Calgary, Alberta--(Newsfile Corp. - May 28, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company") provides an update regarding the filing of its audited annual financial... ► Artikel lesen | |
| SIMPLY SOLVENTLESS CONCENTRATES Aktie jetzt für 0€ handeln | |||||
| 13.05. | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order | 592 | Newsfile | Calgary, Alberta--(Newsfile Corp. - May 12, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company"), provides an update regarding the filing of its audited annual financial... ► Artikel lesen | |
| 30.04. | Simply Solventless Concentrates Ltd: Simply Solventless to be late to file 2025 results | 1 | Stockwatch | ||
| 30.04. | Simply Solventless Concentrates Ltd.: Simply Solventless Announces a Delay in Filing 2025 Annual Financial Statements and Related Management's Discussion and Analysis to Approximately May 11, 2026 | 568 | Newsfile | Calgary, Alberta--(Newsfile Corp. - April 30, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company"), announces that it will not be in a position to file its audited... ► Artikel lesen | |
| 06.04. | Simply Solventless Concentrates Ltd: Simply Solventless receives OK for DIP financing, SISP | 3 | Stockwatch | ||
| 06.04. | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Restructuring Update, Including Expected Timing, and Announces Management Change | 511 | Newsfile | Not for distribution to U.S. news wire services or for dissemination in the United States.Calgary, Alberta--(Newsfile Corp. - April 6, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC")... ► Artikel lesen | |
| 03.03. | Simply Solventless Concentrates Ltd: Simply Solventless debtholders support restructuring | 2 | Stockwatch | ||
| 02.03. | Simply Solventless Concentrates Ltd.: Simply Solventless Announces Endorsement and Support of Restructuring Plan from Secured Debt Holders | 291 | Newsfile | Not for distribution to U.S. news wire services or for dissemination in the United States.Calgary, Alberta--(Newsfile Corp. - March 2, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC")... ► Artikel lesen | |
| 02.03. | XFRA Y3I: WIEDERAUFNAHME/RESUMPTION | 404 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 28.02. | Simply Solventless Concentrates Ltd: Simply Solventless begins restructuring process | 2 | Stockwatch | ||
| 27.02. | Simply Solventless Concentrates Ltd.: Simply Solventless Commences Restructuring Process for the Benefit of Shareholders and Stakeholders | 527 | Newsfile | Calgary, Alberta--(Newsfile Corp. - February 27, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC") announces that it has commenced a restructuring process for the benefit of SSC's... ► Artikel lesen | |
| 27.02. | XFRA Y3I: AUSSETZUNG/SUSPENSION | 619 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILSIMPLY SOLVENT.CONC.... ► Artikel lesen | |
| 22.01. | Simply Solventless Concentrates Ltd: Simply Solventless enters definitive deal for Uncommon | 2 | Stockwatch | ||
| 22.01. | Simply Solventless Concentrates Ltd.: Simply Solventless Announces Acquisition of Brand Uncommon Cannabis Co., Provides Commercial Update, and Announces Conversion of $1.0 Million Promissory Notes to Equity at $0.20/Unit | 516 | Newsfile | Not for distribution to U.S. news wire services or for dissemination in the United States.Calgary, Alberta--(Newsfile Corp. - January 22, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH)... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 49,810 | -1,76 % | Märkte am Morgen: Bayer, Deutsche Bank, SAP, Delivery Hero, Easyjet, ASML | Der DAX hat in der vergangenen Woche abgeliefert. Ein Plus von 4,5 Prozent bedeutet die beste Handelswoche seit April 2025. Vor allem an den letzten Tagen blies der DAX zur Rekordjagd, stellte eine... ► Artikel lesen | |
| MERCK KGAA | 139,10 | -0,36 % | Aktien Frankfurt Ausblick: Dax kaum bewegt nach Rekord | FRANKFURT (dpa-AFX) - Nach seinem Rekordlauf in der vergangenen Woche dürfte der Dax am Montag seine Gewinne halten. Stützend wirken teils freundliche Aktienmärkte in Asien. Dort sorge die Aussicht... ► Artikel lesen | |
| NOVO NORDISK | 43,090 | -0,66 % | Novo Nordisk: Kursziel rauf | Stück für Stück arbeitet sich die Aktie von Novo Nordisk aus dem Tal der Tränen. Zum Start in die neue Handelswoche verbucht das Papier des dänischen Biopharma-Konzerns an der Heimatbörse in Kopenhagen... ► Artikel lesen | |
| PMGC | 1,110 | -0,89 % | PMGC Holdings Inc.: NorthStrive Biosciences to Advance EL-22 Manufacturing Characterization with Quantitative FACS Analysis of Latent Myostatin Antigen Expression | Independent flow cytometry (FACS) study will quantify latent myostatin antigen expression on NorthStrive-manufactured Lactobacillus casei and establish comparability against EL-22 material previously... ► Artikel lesen | |
| KAZIA THERAPEUTICS | 13,540 | -0,15 % | Kazia Therapeutics Limited: Kazia Therapeutics Appoints James Levine as Chief Financial Officer | SYDNEY, June 2, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia," "Kazia Therapeutics" or the "Company"), a clinical-stage oncology company... ► Artikel lesen | |
| BRIGHT MINDS BIOSCIENCES | 77,84 | 0,00 % | Motorola Solutions Foundation and Calculated Genius Honor Chicagoland Future Engineers With 2026 Bright Minds, Bold Futures Scholarship | NORTHAMPTON, MA / ACCESS Newswire / June 30, 2026 / Ten extraordinary Chicagoland high school seniors recently gathered at Motorola Solutions' global headquarters in Chicago, joined by family members... ► Artikel lesen | |
| PFIZER | 21,245 | +0,24 % | JPMORGAN stuft PFIZER INC auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat das Kursziel für Pfizer von 30 auf 28 US-Dollar gesenkt und die Einstufung auf "Neutral" belassen. Seine Schätzungen für die Quartalszahlen am... ► Artikel lesen | |
| KARDIGAN | 24,550 | -0,34 % | TD Cowen initiates Kardigan stock with buy rating on cardiology pipeline | ||
| ETON PHARMACEUTICALS | 36,720 | +0,30 % | Eton Pharmaceuticals Aktie erreicht Rekordhoch von 38,6 USD | ||
| LB PHARMACEUTICALS | 32,950 | 0,00 % | LB Pharmaceuticals Inc: LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) | ||
| ELI LILLY | 1.033,40 | -0,73 % | Megatrend Folger: Eli Lilly sprengt die Billionen-Marke | Eli Lilly marschiert weiter an der Spitze des globalen Gesundheitssektors. Die Aktie des US-Pharmagiganten kletterte am Dienstag auf ein neues Allzeithoch und lässt damit die Marke von einer Billion... ► Artikel lesen | |
| NOVARTIS | 134,50 | -0,50 % | Novartis kauft Myricx Bio für bis zu 1,5 Mrd US-Dollar | DJ Novartis kauft Myricx Bio für bis zu 1,5 Mrd US-Dollar
Von Aimee Look
DOW JONES--Der Schweizer Pharmakonzern Novartis hat die Übernahme des britischen Biotechunternehmens Myricx Bio... ► Artikel lesen | |
| CHINA PHARMA HOLDINGS | 0,635 | 0,00 % | China Pharma: Keine Erklärung für ungewöhnliche Handelsaktivitäten | ||
| SCHOTT PHARMA | 20,700 | +3,50 % | DEUTSCHE BANK RESEARCH stuft Schott Pharma auf 'Buy' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für Schott Pharma von 16 auf 22 Euro angehoben und die Aktien von "Hold" auf "Buy" hochgestuft. Der Spezialist für Verpackung und... ► Artikel lesen | |
| ASTRAZENECA | 148,50 | -1,23 % | BERNSTEIN RESEARCH stuft ASTRAZENECA auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat das Kursziel für Astrazeneca von 18600 auf 18900 Pence angehoben und die Einstufung auf "Outperform" belassen. Vielversprechende... ► Artikel lesen |